Medtronic PLC  

(Public, NYSE:MDT)   Watch this stock  
Find more results forMDT
71.40
-1.61 (-2.21%)
Jan 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 71.21 - 72.92
52 week 53.33 - 77.39
Open 72.84
Vol / Avg. 15.81M/10.29M
Mkt cap 101,304.20M
P/E 24.64
Div/yield 0.31/1.71
EPS 2.90
Shares 984.32M
Beta 1.07
Inst. own 0%
Feb 17, 2015
Q3 2015 Medtronic Inc Earnings Release - 9:30am GMT-5 - Add to calendar
Feb 17, 2015
Q3 2015 Medtronic Inc Earnings Call Add to calendar
Jan 12, 2015
Medtronic Inc at JPMorgan Healthcare Conference
Jan 6, 2015
Medtronic Inc Extraordinary Shareholders Meeting
Dec 10, 2014
Medtronic Inc. at Oppenheimer Healthcare Conference - Webcast
Nov 18, 2014
Q2 2015 Medtronic Inc Earnings Release
Nov 18, 2014
Q2 2015 Medtronic Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '14) 2014
Net profit margin 18.96% 18.02%
Operating margin 25.45% 22.42%
EBITD margin - 33.33%
Return on average assets 8.70% 8.42%
Return on average equity 17.17% 16.08%
Employees 49,000 -
CDP Score - 61 D

Address

20 On Hatch, Lower Hatch Street
DUBLIN, 2
Ireland
+353-1-6492000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Medtronic plc, formerly Medtronic, Inc. is a medical technology, services and solutions company. The Company offers its products to hospitals, physicians, clinicians and patients in over 160 countries. The Company�s portfolio includes surgical, respiratory and monitoring, and vascular therapies solutions along with a line of patient care products to alleviate pain, restore health and extend life for people. The Company operates in three segments: Cardiac and Vascular Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment manufactures and markets device-based medical therapies for Cardiac Rhythm Disease Management (CRDM), Coronary, Structural Heart and Endovascular. The Restorative Therapies Group segment manufactures and markets device-based medical therapies for Spine, Neuromodulation and Surgical Technologies. The Diabetes Group segment manufactures and markets device-based medical therapies for diabetes.